TOKYO -- Asia accounts for less than 50% of the world's cancer patients but almost 60% of cancer deaths, partly due to lack of early detection.
Pharmaceuticals
SoftBank-backed biotech firm brings Asia cancer diagnostic tools
AI innovator Guardant Health will launch lab in Japan, seeks partners in China
A new technology allows physicians to detect cancer through a blood test. (Photo courtesy of Guardant Health)
Read Next
Latest on Pharmaceuticals
